Plasma 24-metabolite panel predicts preclinical transition to clinical stages of Alzheimer’s disease
We recently documented plasma lipid dysregulation in preclinical late-onset Alzheimer’s disease (LOAD). A ten plasma lipid panel, predicted phenoconversion and provided 90% sensitivity and 85% specificity in differentiating an at-risk group from those that would remain cognitively intact. Despite t...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00237/full |